52 related articles for article (PubMed ID: 24837351)
1. A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma.
Herr DJ; Wang C; Mendiratta-Lala M; Matuszak M; Mayo CS; Cao Y; Parikh ND; Ten Haken R; Owen D; Evans JR; Stanescu T; Yan M; Dawson LA; Schipper M; Lawrence TS; Cuneo KC
Clin Cancer Res; 2023 Oct; 29(19):3852-3858. PubMed ID: 37471457
[TBL] [Abstract][Full Text] [Related]
2. Strategies for prediction and mitigation of radiation-induced liver toxicity.
Toesca DAS; Ibragimov B; Koong AJ; Xing L; Koong AC; Chang DT
J Radiat Res; 2018 Mar; 59(suppl_1):i40-i49. PubMed ID: 29432550
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience.
Drewes R; Omari J; Manig M; Seidensticker M; Hass P; Ricke J; Powerski M; Pech M
J Contemp Brachytherapy; 2019 Aug; 11(4):329-336. PubMed ID: 31523233
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma.
Kuo HT; Que J; Lin LC; Yang CC; Koay LB; Lin CH
Medicine (Baltimore); 2017 Dec; 96(50):e9249. PubMed ID: 29390360
[TBL] [Abstract][Full Text] [Related]
5. Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy.
Song JH; Jeong BK; Choi HS; Jeong H; Lee YH; Kim HJ; Kim TH; Jung WT; Lee OJ; Jang HS; Choi BO; Kang KM
J Cancer; 2017; 8(19):4155-4161. PubMed ID: 29187892
[TBL] [Abstract][Full Text] [Related]
6. Strategies to tackle the challenges of external beam radiotherapy for liver tumors.
Lock MI; Klein J; Chung HT; Herman JM; Kim EY; Small W; Mayr NA; Lo SS
World J Hepatol; 2017 May; 9(14):645-656. PubMed ID: 28588749
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.
Que J; Kuo HT; Lin LC; Lin KL; Lin CH; Lin YW; Yang CC
BMC Cancer; 2016 Jul; 16():451. PubMed ID: 27405814
[TBL] [Abstract][Full Text] [Related]
8. Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.
Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kishimoto Y; Okubo Y; Makino H; Tsukamoto N; Igarashi Y; Sumino Y
World J Gastroenterol; 2015 Dec; 21(48):13490-9. PubMed ID: 26730160
[TBL] [Abstract][Full Text] [Related]
9. Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions.
Bae SH; Kim MS; Jang WI; Cho CK; Yoo HJ; Kim KB; Han CJ; Park SC; Lee DH
J Korean Med Sci; 2015 Aug; 30(8):1055-61. PubMed ID: 26240482
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for liver tumors.
Maingon P; Nouhaud É; Mornex F; Créhange G
Cancer Radiother; 2014; 18(4):313-9. PubMed ID: 24958684
[TBL] [Abstract][Full Text] [Related]
11. [Stereotactic body radiation therapy in the management of liver tumours].
Jacob J; Nguyen F; Deutsch E; Mornex F
Cancer Radiother; 2014 Oct; 18(5-6):486-94. PubMed ID: 25195113
[TBL] [Abstract][Full Text] [Related]
12. Robotic stereotactic body radiation therapy for tumors of the liver: radiation-induced liver disease, incidence and predictive factors.
Janoray G; Chapet S; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
Cancer Radiother; 2014 Jun; 18(3):191-7. PubMed ID: 24837351
[TBL] [Abstract][Full Text] [Related]
13. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
[TBL] [Abstract][Full Text] [Related]
15. Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial.
Scorsetti M; Arcangeli S; Tozzi A; Comito T; Alongi F; Navarria P; Mancosu P; Reggiori G; Fogliata A; Torzilli G; Tomatis S; Cozzi L
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):336-42. PubMed ID: 23433800
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
